Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grubbs

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Oncology Reports|February 22, 2001
Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer preventionC Rodríguez-Burford, R A Lubet, V E Steele, et al.
Oncology Reports|February 7, 2012
Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancersRonald A Lubet, Margie L Clapper, David L McCormick, et al.
Anti-Cancer Drug Design|January 1, 1997
Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancerY F Shealy, J L Frye, J M Riordan, et al.
Cancer Letters|October 29, 2003
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancersClinton J Grubbs, Donald L Hill, Kirby I Bland, et al.
Cancer Biology & Therapy|February 7, 2009
Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoidWen Jiang, Wentao Deng, Sarah K Bailey, et al.
Anti-Cancer Drug Design|May 22, 1998
Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)Y F Shealy, J L Frye, D L Hill, et al.
Carcinogenesis|December 14, 2005
Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkersClinton J Grubbs, Ronald A Lubet, Venkatram R Atigadda, et al.
Carcinogenesis|June 1, 1996
Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in ratsM A Pereira, C J Grubbs, L H Barnes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 19, 2013
Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer modelHolly L Nicastro, Clinton J Grubbs, M Margaret Juliana, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trialRonald D Alvarez, Michael G Conner, Heidi Weiss, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Oncology Reports|February 22, 2001
Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer preventionC Rodríguez-Burford, R A Lubet, V E Steele, et al.
Oncology Reports|February 7, 2012
Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancersRonald A Lubet, Margie L Clapper, David L McCormick, et al.
Anti-Cancer Drug Design|January 1, 1997
Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancerY F Shealy, J L Frye, J M Riordan, et al.
Cancer Letters|October 29, 2003
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancersClinton J Grubbs, Donald L Hill, Kirby I Bland, et al.
Cancer Biology & Therapy|February 7, 2009
Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoidWen Jiang, Wentao Deng, Sarah K Bailey, et al.
Anti-Cancer Drug Design|May 22, 1998
Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)Y F Shealy, J L Frye, D L Hill, et al.
Carcinogenesis|December 14, 2005
Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkersClinton J Grubbs, Ronald A Lubet, Venkatram R Atigadda, et al.
Carcinogenesis|June 1, 1996
Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in ratsM A Pereira, C J Grubbs, L H Barnes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 19, 2013
Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer modelHolly L Nicastro, Clinton J Grubbs, M Margaret Juliana, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trialRonald D Alvarez, Michael G Conner, Heidi Weiss, et al.
Pageof 16